ANI Pharmaceuticals | ANIP - الأصول





الأصول تغيير تاريخ
AbbVie USD 147.68B 12.57B 2026-09
ANI Pharmaceuticals USD 1.57B 73.55M 2026-09
Aurora Cannabis CAD 620.88M 19.79M 2026-06
Canopy Growth CAD 1.1B 14.81M 2026-06
Eli Lilly USD 148.07B 5.79B 2026-09
Emergent BioSolutions USD 1.82B 69.9M 2023-12
Heron Therapeutics USD 230.45M 21.81M 2026-09
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Nektar Therapeutics USD 763.27M 482.86M 2026-03
Novartis USD 117.15B 1.38B 2026-09
Omeros USD 200.57M 34.59M 2025-06
Perrigo USD 7.48B 124.6M 2026-09
Sun Pharmaceuticals INR 1.15T 60.53B 2026-09
Teva Pharmaceutical Industries USD 40.04B 185M 2026-09